Fibrosis Stages: F0 to F4, Score to Elastography for Patients
Liver fibrosis stages range from F0, meaning no scarring, to F4, meaning cirrhosis, with each step marking more tissue damage and less flexibility in the liver. Earlier stages often improve once the underlying cause is treated, while F3 and F4 usually call for specialist monitoring and screening for complications. Staging comes from a combination of blood work, elastography, and sometimes a liver biopsy.
TL;DR: F3 and F4 are often managed together as compensated advanced chronic liver disease, with specialist care and surveillance even when symptoms are absent. The initial blood score uses age, liver enzymes, and platelet count; results below 1.3 usually rule out advanced fibrosis, though age shifts the threshold. Elastography works better for advanced fibrosis and cirrhosis than early stages, so clinicians use it to assess advanced disease, not pinpoint an exact stage. Ask whether a stiffness result has been repeated, because recent alcohol use or active inflammation can affect a single reading and alter the apparent stage.
Precision Digestive Healthprecisiondigestive.comGet Support for Liver FibrosisDr. Meet Parikh provides liver disease care and gastroenterology services in South Plainfield, NJ for patients seeking evaluation and ongoing care.Explore liver care
Table of Contents
- What each fibrosis stage means
- How fibrosis is assessed: blood tests, elastography, and biopsy
- What staging means for prognosis and follow-up care
- Causes, symptoms, and what speeds up progression
- When to get tested and what happens next
- How we approach fibrosis evaluation at our practice
- Get specialist support for liver fibrosis and diagnosis
- FAQ
- Sources
What each fibrosis stage means
The METAVIR system describes fibrosis as a five-point scale, and each stage reflects how much scar tissue has replaced healthy liver structure.
- F0: no fibrosis, with normal liver architecture on tissue exam.
- F1: mild fibrosis, limited to small areas around the portal tracts.
- F2: moderate fibrosis, with scarring that has started to bridge portal areas, generally viewed as clinically significant.
- F3: severe fibrosis, with bridging scar tissue spreading between portal and vascular structures.
- F4: cirrhosis, where scarring has reorganized the liver into nodules and normal function is compromised.
Biopsy-based staging looks at a small tissue sample under a microscope, and a pathologist scores the pattern and amount of scarring. Because a biopsy only captures a tiny fraction of the liver, sampling variability can blur the line between adjacent stages, which is part of why noninvasive tests have become central to diagnosis.
Clinicians increasingly group F3 and F4 together under the term compensated advanced chronic liver disease, or cACLD, since both carry a meaningfully higher risk of complications and both call for similar surveillance regardless of the exact numeric stage.
How fibrosis is assessed: blood tests, elastography, and biopsy
Diagnosis typically starts with blood-based scores before moving to imaging. The NIDDK’s guidance on diagnosing cirrhosis describes a workup that combines history, physical exam, liver enzymes, platelet counts, and imaging, with biopsy reserved for cases that remain unclear.
FIB-4 is usually the first step. It is calculated from age, AST, ALT, and platelet count, and a result below 1.3 is generally used to rule out advanced fibrosis in many populations, though the threshold shifts somewhat with age.
- FIB-4: a low-cost blood-based score used as the initial screen in primary care.
- VCTE (FibroScan): measures liver stiffness in kilopascals and performs best at identifying cirrhosis.
- MRE: magnetic resonance elastography, generally more accurate than VCTE but less widely available.
- pSWE and 2D SWE: ultrasound-based stiffness measurements used in some centers as alternatives to VCTE.
- Liver biopsy: still used when noninvasive results are indeterminate or conflict with the clinical picture.
A review on elastography in liver disease notes that stiffness measurements work best for distinguishing advanced fibrosis and cirrhosis from milder disease, while accuracy drops and stage overlap increases at the earlier end of the scale. This is one reason guideline authors increasingly frame the goal as ruling advanced disease in or out rather than pinpointing an exact stage.
A meta-analysis of transient elastography found that its sensitivity and specificity for detecting cirrhosis and severe fibrosis are generally high, supporting its use as a reliable tool to rule out advanced disease in many patients, according to a meta-analysis on elastography accuracy.
What staging means for prognosis and follow-up care
Where you land on the fibrosis scale shapes what happens next. Earlier stages are usually managed by addressing the root cause, such as reducing alcohol use, losing weight, or starting antiviral treatment, paired with periodic monitoring rather than invasive procedures.
Once someone reaches F3 or F4, care typically shifts to a specialist, with structured surveillance added to routine management:
- Repeat liver stiffness testing on a scheduled basis to track trends.
- Screening for esophageal varices through endoscopy, since advanced scarring raises bleeding risk.
- Periodic imaging to screen for liver cancer (hepatocellular carcinoma), a known risk in cirrhosis.
- Lab monitoring of liver function and markers of complications over time.
The cACLD framing matters here because F3 and F4 often behave similarly in people who still feel well, so clinicians focus less on the exact number and more on whether advanced disease can be confidently ruled in or out, a distinction supported by elastography research described in a review of noninvasive liver testing.
Pro Tip: Ask your clinician whether your result reflects a single test or a trend across repeat measurements, since one-off stiffness readings can be affected by recent alcohol use or active inflammation.
Causes, symptoms, and what speeds up progression
Fibrosis develops gradually in response to repeated liver injury, and the underlying cause often predicts how it behaves over time.
- Metabolic-associated fatty liver disease (MASLD/NAFLD): linked to obesity, insulin resistance, and type 2 diabetes.
- Viral hepatitis (hepatitis B and C): causes ongoing inflammation that can progress if untreated.
- Alcohol-related liver disease: damage that is closely tied to the amount and duration of drinking.
- Autoimmune and cholestatic conditions: less common causes that still follow a similar fibrosis pathway.
Early fibrosis rarely produces symptoms, which is why many people reach F2 or beyond before any testing happens. Warning signs tend to appear only once disease is advanced, including fatigue, swelling in the legs or abdomen, easy bruising, or yellowing of the skin and eyes. Ongoing alcohol use, poorly controlled diabetes, untreated viral infection, and persistent metabolic syndrome are the factors most consistently tied to faster progression between stages.
When to get tested and what happens next
Testing usually follows a clear path, starting with the most accessible option before moving toward imaging or biopsy.
- Start with FIB-4 if you have risk factors like fatty liver, heavy alcohol use, viral hepatitis, or elevated liver enzymes found incidentally.
- Move to elastography (VCTE, MRE, or shear wave imaging) if FIB-4 suggests intermediate or higher risk, since this adds a direct stiffness measurement.
- Consider biopsy if elastography and blood work disagree, or if a precise diagnosis is needed to guide treatment, a step the NIDDK’s overview of liver biopsy describes as the reference standard in indeterminate cases.
An elastography visit is brief and noninvasive: a probe placed against the skin measures how fast a vibration travels through liver tissue, and the appointment usually takes well under an hour. A low-stiffness result often means continued monitoring in primary care, while a higher result typically triggers referral to a gastroenterologist or hepatologist.
Pro Tip: Bring recent lab results (AST, ALT, platelet count) to your first liver-related visit so your clinician can calculate FIB-4 without ordering duplicate tests.
How we approach fibrosis evaluation at our practice
We follow a guideline-aligned, two-step approach to fibrosis risk stratification, starting with blood-based scoring and moving to elastography or specialist referral when results suggest intermediate or advanced disease. We aim to provide patients with a clear understanding of their condition and appropriate monitoring or treatment options.
For readers who want a starting point, our liver health checklist walks through self-assessment questions, and our liver disease management page outlines how we coordinate testing and ongoing care for patients with fibrosis or cirrhosis.
— Precision Digestive Health
Get specialist support for liver fibrosis and diagnosis
If you have risk factors for fibrosis or a test result that needs a closer look, we offer liver disease management that includes specialist consultation, referral for elastography, and coordination of lab work so you are not left interpreting numbers alone.
Our team works directly with patients to figure out the right next test and the right follow-up schedule based on where they fall on the fibrosis scale. Visit our liver disease management page to schedule a consultation and get a clear plan for your liver health.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
Is early stage fibrosis reversible?
Early fibrosis, generally F0 through F2, often improves or stabilizes once the underlying cause is treated, such as through alcohol cessation, weight loss, or antiviral therapy for viral hepatitis. Advanced stages like cirrhosis are harder to reverse, which is part of why clinicians emphasize catching fibrosis early.
Does liver fibrosis cause pain?
Early-stage fibrosis typically causes no noticeable symptoms, which is why many cases are found incidentally through blood tests or imaging. Discomfort or pain is more likely to appear with advanced disease, often alongside fatigue, swelling, or other signs of declining liver function.
Can liver failure cause swelling?
Yes, swelling in the legs, feet, or abdomen is a recognized sign of advanced liver disease, including decompensated cirrhosis, and reflects fluid buildup as liver function declines. This type of swelling is one of the surveillance targets clinicians watch for once someone reaches advanced fibrosis stages.
How does cirrhosis affect kidney function?
Advanced cirrhosis can disrupt blood flow and fluid balance in ways that strain kidney function over time, which is one reason specialists monitor kidney markers alongside liver tests in patients with cirrhosis. This connection is part of why ongoing specialist follow-up matters once fibrosis reaches an advanced stage.
How is fibrosis staged if blood tests and elastography disagree?
When noninvasive tests give conflicting or indeterminate results, a liver biopsy remains the reference standard for confirming the exact stage, according to the NIDDK’s guidance on liver biopsy. This is typically reserved for cases where the diagnosis affects treatment decisions.
Sources
- NIDDK: Diagnosing cirrhosis
- Update on the role of elastography in liver disease (review)
- Meta-analysis on transient elastography diagnostic accuracy
